BrightSpring Health (BTSG) | Financial Analysis & Statements
BrightSpring Health Services Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
3.6B
Gross Profit
412.5M
11.62%
Operating Income
108.1M
3.04%
Net Income
77.3M
2.18%
EPS (Diluted)
$0.35
Balance Sheet Metrics
Total Assets
6.4B
Total Liabilities
4.5B
Shareholders Equity
1.9B
Debt to Equity
2.40
Cash Flow Metrics
Operating Cash Flow
196.8M
Free Cash Flow
193.9M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
BrightSpring Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 12.9B | 11.3B | 8.8B | 7.7B | 6.7B |
| Cost of Goods Sold | 11.4B | 9.7B | 7.4B | 6.4B | 5.4B |
| Gross Profit | 1.5B | 1.6B | 1.4B | 1.4B | 1.2B |
| Gross Margin % | 11.8% | 14.1% | 16.2% | 17.5% | 18.6% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 1.2B | 1.4B | 1.3B | 1.1B | 1.0B |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 1.2B | 1.4B | 1.3B | 1.1B | 1.0B |
| Operating Income | 295.3M | 206.4M | 147.2M | 228.7M | 234.2M |
| Operating Margin % | 2.3% | 1.8% | 1.7% | 3.0% | 3.5% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 157.3M | 228.4M | 324.6M | 233.6M | 165.3M |
| Other Non-Operating Income | - | -12.7M | - | -40.9M | - |
| Pre-tax Income | 137.9M | -34.7M | -177.4M | -45.8M | 68.9M |
| Income Tax | 33.1M | -14.2M | -20.6M | 8.5M | 17.6M |
| Effective Tax Rate % | 24.0% | 0.0% | 0.0% | 0.0% | 25.6% |
| Net Income | 189.1M | -20.5M | -156.8M | -54.2M | 51.3M |
| Net Margin % | 1.5% | -0.2% | -1.8% | -0.7% | 0.8% |
| Key Metrics | |||||
| EBITDA | 459.5M | 410.9M | 349.5M | 432.7M | 433.3M |
| EPS (Basic) | - | $-0.09 | $-0.90 | $-0.31 | $0.29 |
| EPS (Diluted) | - | $-0.09 | $-0.90 | $-0.31 | $0.29 |
| Basic Shares Outstanding | - | 192997000 | 171190389 | 171190389 | 171190389 |
| Diluted Shares Outstanding | - | 192997000 | 171190389 | 171190389 | 171190389 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
BrightSpring Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 88.4M | 61.3M | 13.1M | 13.6M | 46.7M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 989.7M | 1.0B | 881.6M | 775.8M | 730.3M |
| Inventory | 815.2M | 640.6M | 402.8M | 430.5M | 299.2M |
| Other Current Assets | 16.8M | 14.0M | 13.2M | 13.5M | 12.7M |
| Total Current Assets | 2.9B | 1.9B | 1.5B | 1.3B | 1.2B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 211.3M | 347.3M | 350.8M | 317.2M | 356.0M |
| Goodwill | 5.6B | 6.2B | 6.1B | 6.1B | 6.4B |
| Intangible Assets | 557.6M | 811.5M | 881.5M | 975.9M | 1.1B |
| Long-term Investments | - | 0 | 24.9M | 36.8M | 0 |
| Other Non-Current Assets | 21.8M | 32.0M | 32.2M | 24.3M | 27.2M |
| Total Non-Current Assets | 3.5B | 4.0B | 4.1B | 4.1B | 4.3B |
| Total Assets | 6.4B | 5.9B | 5.5B | 5.4B | 5.5B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.2B | 941.3M | 641.6M | 526.9M | 408.1M |
| Short-term Debt | 102.1M | 130.5M | 114.5M | 107.9M | 125.2M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 197.4M | - | - | - | - |
| Total Current Liabilities | 1.8B | 1.4B | 1.2B | 932.5M | 892.2M |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.6B | 2.8B | 3.6B | 3.6B | 3.6B |
| Deferred Tax Liabilities | 6.2M | 0 | 23.7M | 79.4M | 98.2M |
| Other Non-Current Liabilities | 1.5M | 11.4M | 18.0M | 7.7M | 7.3M |
| Total Non-Current Liabilities | 2.7B | 2.8B | 3.7B | 3.7B | 3.8B |
| Total Liabilities | 4.5B | 4.3B | 4.9B | 4.7B | 4.7B |
| Equity | |||||
| Common Stock | 1.9M | 1.7M | 1.2M | 1.2M | 1.2M |
| Retained Earnings | -74.6M | -222.2M | -200.3M | -45.7M | 971.0K |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.9B | 1.7B | 612.5M | 784.1M | 800.5M |
| Key Metrics | |||||
| Total Debt | 2.7B | 2.9B | 3.7B | 3.7B | 3.8B |
| Working Capital | 1.0B | 464.7M | 208.2M | 411.7M | 288.5M |
Balance Sheet Composition
BrightSpring Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 189.1M | -20.5M | -156.8M | -54.2M | 51.3M |
| Depreciation & Amortization | 164.3M | 204.5M | 202.3M | 204.0M | 199.2M |
| Stock-Based Compensation | 70.1M | 69.2M | 3.9M | 3.5M | 4.5M |
| Working Capital Changes | -81.2M | -133.1M | 702.0K | -154.2M | -63.0M |
| Operating Cash Flow | 356.6M | 103.7M | 17.8M | -5.7M | 219.7M |
| Investing Activities | |||||
| Capital Expenditures | -95.5M | -80.9M | -73.5M | -70.1M | -59.3M |
| Acquisitions | -204.6M | -59.8M | -63.1M | 113.3M | -1.1B |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -305.1M | -140.2M | -134.4M | 45.4M | -1.2B |
| Financing Activities | |||||
| Share Repurchases | -43.2M | -650.0K | -650.0K | 0 | -417.0K |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 0 | 2.6B | 0 | 0 | 767.7M |
| Debt Repayment | -127.1M | -3.4B | -66.1M | -68.9M | -40.8M |
| Financing Cash Flow | -183.1M | 163.1M | -67.5M | -74.0M | 705.0M |
| Free Cash Flow | 394.7M | -57.1M | 137.3M | -74.8M | 210.9M |
| Net Change in Cash | -131.7M | 126.6M | -184.1M | -34.4M | -266.0M |
Cash Flow Trend
BrightSpring Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
100.33
Forward P/E
24.63
Price to Book
5.24
Price to Sales
0.72
PEG Ratio
0.27
Profitability Ratios
Profit Margin
1.48%
Operating Margin
3.05%
Return on Equity
5.92%
Return on Assets
3.27%
Financial Health
Current Ratio
1.56
Debt to Equity
143.60
Beta
2.05
Per Share Data
EPS (TTM)
$0.48
Book Value per Share
$9.20
Revenue per Share
$63.74
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| BTSG | 9.3B | 100.33 | 5.24 | 5.92% | 1.48% | 143.60 |
| Ge Healthcare | 31.9B | 15.92 | 3.18 | 22.38% | 10.10% | 98.72 |
| Veeva Systems | 26.5B | 29.57 | 3.66 | 13.93% | 28.45% | 1.33 |
| Tempus AI | 9.4B | 39.30 | 18.89 | -89.48% | -19.27% | 270.11 |
| HealthEquity | 6.6B | 31.61 | 3.14 | 10.19% | 16.39% | 47.53 |
| Waystar Holding | 4.8B | 40.74 | 1.23 | 3.22% | 10.20% | 38.45 |
Financial data is updated regularly. All figures are in the company's reporting currency.






